Revolution Medicines (RVMD) Non Operating Interest Expenses (2019 - 2026)
Revolution Medicines (RVMD) posted Non Operating Interest Expenses of $23.8 million for Q2 2026, up 94.97% on a QoQ basis from $12.2 million in Q1 2026, and up 2642.91% year-over-year from $867000.0 in Q2 2025.
Powered by 
Analysis
Revolution Medicines (RVMD) Non Operating Interest Expenses (2019 - 2026) Analysis & Trends
Revolution Medicines has reported Non Operating Interest Expenses for 6 years, with the latest figure at $23.8 million in Q2 2026.
- On a quarterly basis, Non Operating Interest Expenses rose 2642.91% year-over-year to $23.8 million in Q2 2026; TTM through Jun 2026 was $59.3 million, a 3155.72% increase from a year earlier, with the FY2025 full-year figure at $24.2 million, up 858.5% from the prior year.
- Non Operating Interest Expenses was $23.8 million for Q2 2026 at Revolution Medicines, up from $12.2 million in the prior quarter.
- The five-year high for Non Operating Interest Expenses was $23.8 million in Q2 2026, with the low at -$2.8 million in Q4 2024.
- Average Non Operating Interest Expenses over 3 years is $8.6 million, with a median of $11.4 million recorded in 2025.
- The sharpest annual moves came in 2025 and 2026: Non Operating Interest Expenses soared 524.92% in 2025, then jumped 2642.91% in 2026.
- Over 3 years, Non Operating Interest Expenses stood at -$2.8 million in 2024, then jumped by 524.92% to $11.9 million in 2025, then surged by 99.24% to $23.8 million in 2026.
- The last three Non Operating Interest Expenses figures came in at $23.8 million (Q2 2026), $12.2 million (Q1 2026), and $11.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | - |
| 10 | Revolution Medicines | 40.86 Bn | 40.86 Bn | - | 23.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.78 Mn |
| Mar 31, 2026 | 12.20 Mn |
| Dec 31, 2025 | 11.94 Mn |
| Sep 30, 2025 | 11.43 Mn |
| Jun 30, 2025 | 867,000.00 |
| Dec 31, 2024 | -2.81 Mn |
| Mar 31, 2024 | 2.81 Mn |
| Mar 31, 2021 | 12,000.00 |
| Dec 31, 2020 | 14,000.00 |
| Sep 30, 2020 | 17,000.00 |
| Jun 30, 2020 | 19,000.00 |
| Mar 31, 2020 | 21,000.00 |
| Dec 31, 2019 | 23,000.00 |
| Sep 30, 2019 | 25,000.00 |
| Jun 30, 2019 | 28,000.00 |
| Mar 31, 2019 | 30,000.00 |
API Access
Revolution Medicines Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();